SLNO
insider transactionsSOLENO THERAPEUTICS INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-14.9K
0 buy · 14.9K sell
Net value · 90d
-$445.8K
$0 in · $445.8K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
8
0 buy · 14.9K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
220.0K sh
Own New
-
Other·D
Director
—
10.0K sh
Own -100%
-
Other·D
Director
—
2.1K sh
Own -100%
-
Other·D
Director
—
2.7K sh
Own -100%
-
Other·D
Director
—
635 sh
Own -100%
-
Other·D
Director
—
823 sh
Own -100%
-
Other·D
Director
—
1.3K sh
Own -100%
-
Other·D
Director
—
10.5K sh
Own -100%
-
Other·D
Director
—
10.0K sh
Own -100%
-
Other·D
Director
—
2.1K sh
Own -100%
-
Other·D
Director
—
2.7K sh
Own -100%
-
Other·D
Director
—
635 sh
Own -100%
-
Other·D
Director
—
1.3K sh
Own -100%
-
Other·D
Director
—
17.5K sh
Own -100%
-
Other·D
Officer title: SVP Global Cli…
—
11.9K sh
Own -100%
-
Other·D
Officer title: SVP Global Cli…
—
13.8K sh
Own -100%
-
Other·D
Officer title: SVP Global Cli…
—
16.0K sh
Own -100%
-
Other·D
Officer title: SVP Global Cli…
—
55.4K sh
Own -100%
-
Other·D
Officer title: SVP Global Cli…
—
11.7K sh
Own -100%
-
Other·D
Officer title: SVP Global Cli…
—
2.4K sh
Own -100%
-
Other·D
Officer title: SVP Global Cli…
—
18.8K sh
Own -100%
-
Other·D
Officer title: SVP Global Cli…
—
666 sh
Own -100%
-
Other·D
Officer title: SVP Global Cli…
—
4.0K sh
Own -100%
-
Other·D
Officer title: SVP Global Cli…
—
5.0K sh
Own -100%
-
Other·D
Officer title: SVP Global Cli…
—
1.7K sh
Own -100%
-
Other·D
Officer title: SVP Global Cli…
—
37.6K sh
Own -100%
-
Other·D
Director
—
9.1K sh
Own -100%
-
Other·D
Director
—
10.5K sh
Own -100%
-
Other·D
Chief Business Officer
—
4.0K sh
Own -100%
-
Other·D
Chief Business Officer
—
64.3K sh
Own -100%
-
Other·D
Chief Business Officer
—
17.8K sh
Own -100%
-
Other·D
Chief Commercial Officer
—
32.8K sh
Own -100%
-
Other·D
Chief Commercial Officer
—
29.2K sh
Own -100%
-
Other·D
Chief Commercial Officer
—
91.0K sh
Own -100%
-
Other·D
Chief Commercial Officer
—
64.5K sh
Own -100%
-
Other·D
Chief Development Officer
—
4.7K sh
Own -100%
-
Other·D
Chief Development Officer
—
72.3K sh
Own -100%
-
Other·D
Chief Development Officer
—
20.2K sh
Own -100%
-
Other·D
Sr. VP of Clinical Development
—
11.9K sh
Own -100%
-
Other·D
Sr. VP of Clinical Development
—
13.8K sh
Own -100%
-
Other·D
Sr. VP of Clinical Development
—
110.0K sh
Own -100%
-
Other·D
Sr. VP of Clinical Development
—
39.8K sh
Own -100%
-
Other·D
Officer title: Senior Vice Pr…
—
1.3K sh
Own -100%
-
Other·D
Officer title: Senior Vice Pr…
—
11.9K sh
Own -100%
-
Other·D
Officer title: Senior Vice Pr…
—
13.8K sh
Own -100%
-
Other·D
Officer title: Senior Vice Pr…
—
16.0K sh
Own -100%
-
Other·D
Officer title: Senior Vice Pr…
—
49.3K sh
Own -100%
-
Other·D
Officer title: Senior Vice Pr…
—
11.7K sh
Own -100%
-
Other·D
Officer title: Senior Vice Pr…
—
2.4K sh
Own -100%
-
Other·D
Officer title: Senior Vice Pr…
—
18.8K sh
Own -100%
-
Other·D
Officer title: Senior Vice Pr…
—
2.3K sh
Own -100%
-
Other·D
Officer title: Senior Vice Pr…
—
22.7K sh
Own -100%
-
Other·D
Director
—
10.0K sh
Own -100%
-
Other·D
Jennifer Fulk KEY
CHIEF FINANCIAL OFFICER
—
67.7K sh
Own -100%
-
Other·D
Jennifer Fulk KEY
CHIEF FINANCIAL OFFICER
—
39.2K sh
Own -100%
-
Other·D
Director
—
17.0K sh
Own -100%
-
Other·D
Bhatnagar Anish KEY
CHIEF EXECUTIVE OFFICER
—
131.4K sh
Own -100%
-
Other·D
Bhatnagar Anish KEY
CHIEF EXECUTIVE OFFICER
—
115.6K sh
Own -100%
-
Other·D
Bhatnagar Anish KEY
CHIEF EXECUTIVE OFFICER
—
100.0K sh
Own -100%
-
Other·D
Bhatnagar Anish KEY
CHIEF EXECUTIVE OFFICER
—
200.8K sh
Own -100%
-
Other·D
Bhatnagar Anish KEY
CHIEF EXECUTIVE OFFICER
—
52.7K sh
Own -100%
-
Other·D
Bhatnagar Anish KEY
CHIEF EXECUTIVE OFFICER
—
73.3K sh
Own -100%
-
Other·D
Bhatnagar Anish KEY
CHIEF EXECUTIVE OFFICER
—
8.5K sh
Own -100%
-
Other·D
Bhatnagar Anish KEY
CHIEF EXECUTIVE OFFICER
—
35.0K sh
Own -100%
-
Other·D
Bhatnagar Anish KEY
CHIEF EXECUTIVE OFFICER
—
23.3K sh
Own -100%
-
Other·D
Bhatnagar Anish KEY
CHIEF EXECUTIVE OFFICER
—
60 sh
Own -100%
-
Other·D
Bhatnagar Anish KEY
CHIEF EXECUTIVE OFFICER
—
22.5K sh
Own -100%
-
Other·D
Bhatnagar Anish KEY
CHIEF EXECUTIVE OFFICER
—
583.7K sh
Own -100%
-
Sell·S
Director · 10b5-1
$7.9K
371 sh · $21.36
Own -2%
-
Sell·S
Director · 10b5-1
$8.5K
415 sh · $20.52
Own -3%
-
Sell·S
Chief Commercial Officer
$17.7K
558 sh · $31.72
Own -1%
-
Sell·S
Chief Commercial Officer
$65.2K
2.1K sh · $31.04
Own -3%
-
Sell·S
Chief Commercial Officer
$146.1K
4.9K sh · $30.04
Own -7%
-
Sell·S
Sr. VP of Clinical Development
$15.5K
488 sh · $31.72
Own -1%
-
Sell·S
Sr. VP of Clinical Development
$57.0K
1.8K sh · $31.04
Own -4%
-
Sell·S
Sr. VP of Clinical Development
$127.8K
4.3K sh · $30.04
Own -9%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 20, 2026 | Dawn Carter Bir | Grant A | 220.0K | $0 |
| May 18, 2026 | Andrew Sinclair | Other D | 10.0K | — |
| May 18, 2026 | Andrew Sinclair | Other D | 2.1K | — |
| May 18, 2026 | Andrew Sinclair | Other D | 2.7K | — |
| May 18, 2026 | Andrew Sinclair | Other D | 635 | — |
| May 18, 2026 | Andrew Sinclair | Other D | 823 | — |
| May 18, 2026 | Andrew Sinclair | Other D | 1.3K | — |
| May 18, 2026 | Andrew Sinclair | Other D | 10.5K | — |
| May 18, 2026 | Birgitte Volck | Other D | 10.0K | — |
| May 18, 2026 | Birgitte Volck | Other D | 2.1K | — |
| May 18, 2026 | Birgitte Volck | Other D | 2.7K | — |
| May 18, 2026 | Birgitte Volck | Other D | 635 | — |
| May 18, 2026 | Birgitte Volck | Other D | 1.3K | — |
| May 18, 2026 | Birgitte Volck | Other D | 17.5K | — |
| May 18, 2026 | Kristen Yen | Other D | 11.9K | — |
| May 18, 2026 | Kristen Yen | Other D | 13.8K | — |
| May 18, 2026 | Kristen Yen | Other D | 16.0K | — |
| May 18, 2026 | Kristen Yen | Other D | 55.4K | — |
| May 18, 2026 | Kristen Yen | Other D | 11.7K | — |
| May 18, 2026 | Kristen Yen | Other D | 2.4K | — |
| May 18, 2026 | Kristen Yen | Other D | 18.8K | — |
| May 18, 2026 | Kristen Yen | Other D | 666 | — |
| May 18, 2026 | Kristen Yen | Other D | 4.0K | — |
| May 18, 2026 | Kristen Yen | Other D | 5.0K | — |
| May 18, 2026 | Kristen Yen | Other D | 1.7K | — |
| May 18, 2026 | Kristen Yen | Other D | 37.6K | — |
| May 18, 2026 | Matthew Pauls | Other D | 9.1K | — |
| May 18, 2026 | Matthew Pauls | Other D | 10.5K | — |
| May 18, 2026 | Kevin Norrett | Other D | 4.0K | — |
| May 18, 2026 | Kevin Norrett | Other D | 64.3K | — |
| May 18, 2026 | Kevin Norrett | Other D | 17.8K | — |
| May 18, 2026 | Meredith Manning | Other D | 32.8K | — |
| May 18, 2026 | Meredith Manning | Other D | 29.2K | — |
| May 18, 2026 | Meredith Manning | Other D | 91.0K | — |
| May 18, 2026 | Meredith Manning | Other D | 64.5K | — |
| May 18, 2026 | Manher Joshi | Other D | 4.7K | — |
| May 18, 2026 | Manher Joshi | Other D | 72.3K | — |
| May 18, 2026 | Manher Joshi | Other D | 20.2K | — |
| May 18, 2026 | Michael F. Huang | Other D | 11.9K | — |
| May 18, 2026 | Michael F. Huang | Other D | 13.8K | — |
| May 18, 2026 | Michael F. Huang | Other D | 110.0K | — |
| May 18, 2026 | Michael F. Huang | Other D | 39.8K | — |
| May 18, 2026 | Patricia C Hirano KEY | Other D | 1.3K | — |
| May 18, 2026 | Patricia C Hirano KEY | Other D | 11.9K | — |
| May 18, 2026 | Patricia C Hirano KEY | Other D | 13.8K | — |
| May 18, 2026 | Patricia C Hirano KEY | Other D | 16.0K | — |
| May 18, 2026 | Patricia C Hirano KEY | Other D | 49.3K | — |
| May 18, 2026 | Patricia C Hirano KEY | Other D | 11.7K | — |
| May 18, 2026 | Patricia C Hirano KEY | Other D | 2.4K | — |
| May 18, 2026 | Patricia C Hirano KEY | Other D | 18.8K | — |
| May 18, 2026 | Patricia C Hirano KEY | Other D | 2.3K | — |
| May 18, 2026 | Patricia C Hirano KEY | Other D | 22.7K | — |
| May 18, 2026 | Mark W Hahn | Other D | 10.0K | — |
| May 18, 2026 | Jennifer Fulk KEY | Other D | 67.7K | — |
| May 18, 2026 | Jennifer Fulk KEY | Other D | 39.2K | — |
| May 18, 2026 | Dawn Carter Bir | Other D | 17.0K | — |
| May 18, 2026 | Bhatnagar Anish KEY | Other D | 131.4K | — |
| May 18, 2026 | Bhatnagar Anish KEY | Other D | 115.6K | — |
| May 18, 2026 | Bhatnagar Anish KEY | Other D | 100.0K | — |
| May 18, 2026 | Bhatnagar Anish KEY | Other D | 200.8K | — |
| May 18, 2026 | Bhatnagar Anish KEY | Other D | 52.7K | — |
| May 18, 2026 | Bhatnagar Anish KEY | Other D | 73.3K | — |
| May 18, 2026 | Bhatnagar Anish KEY | Other D | 8.5K | — |
| May 18, 2026 | Bhatnagar Anish KEY | Other D | 35.0K | — |
| May 18, 2026 | Bhatnagar Anish KEY | Other D | 23.3K | — |
| May 18, 2026 | Bhatnagar Anish KEY | Other D | 60 | — |
| May 18, 2026 | Bhatnagar Anish KEY | Other D | 22.5K | — |
| May 18, 2026 | Bhatnagar Anish KEY | Other D | 583.7K | — |
| Apr 2, 2026 | Matthew Pauls 10b5-1 | Sell S | 371 | $7.9K |
| Apr 2, 2026 | Matthew Pauls 10b5-1 | Sell S | 415 | $8.5K |
| Mar 27, 2026 | Meredith Manning | Sell S | 558 | $17.7K |
| Mar 27, 2026 | Meredith Manning | Sell S | 2.1K | $65.2K |
| Mar 27, 2026 | Meredith Manning | Sell S | 4.9K | $146.1K |
| Mar 27, 2026 | Michael F. Huang | Sell S | 488 | $15.5K |
| Mar 27, 2026 | Michael F. Huang | Sell S | 1.8K | $57.0K |
| Mar 27, 2026 | Michael F. Huang | Sell S | 4.3K | $127.8K |
About SLNO insider trading
This page tracks insider transactions for SOLENO THERAPEUTICS INC (SLNO) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.